Renta 4 | Aena (AENA) will publish its 9M25 results on Wednesday, 29 October 2025, at the market opening, with a conference at 1:00 p.m. P.O. €21.03, recommendation to underweight. Driven by air traffic, which in 9M in Spain has exceeded annual forecasts (up 3.9% against 3.4% Aena and Renta 4 guidance, and 3.9% consensus, our forecast is that Aena will update this guidance to around 4%), we expect aeronautical…
CdM | Unicaja (UNI) has launched an interest-bearing online account aimed at new self-employed customers, offering a return of up to 3% APR during the first 12 months. It also includes a 1% refund on the sum of the main direct debits and exemption from maintenance and administration fees. ‘The bank’s objective is to reinforce its commitment to attracting new self-employed customers throughout the country, focusing on a model of…
Renta 4 | Interview with Mr Gabriel Escarrer in Expansión newspaper. Among the comments we highlight: If good acquisition opportunities arise (holiday segment), Meliã would carry out a capital increase, which would not put pressure on cash flow. The current situation for Meliá and the sector is one of ‘normalisation’, after several years of strong growth following Covid-19, in which they grew three times faster than the GDP of the…
Link Securities | Iberdrola (IBE) and Scottish Power have sounded out their rivals about a possible deal involving their UK retail business, as the sector faces high consumer debt and rapid growth from Octopus Energy, according to Expansión newspaper. Iberdrola has reportedly spoken to several companies in the sector about a merger with Scottish Power in response to the challenges facing the retail market, according to people familiar with the…
CdM | OHLA (OHLA) informed the Spanish National Securities Market Commission (CNMV) on Friday that it has reached an agreement in principle with Mohari Hospitality — a global investment firm specialising in the luxury hotel sector — for the division of the Canalejas Complex asset, an agreement that the company describes as ‘positive for both parties’. According to the statement, OHLA will retain ownership of the Canalejas Gallery and the…
Renta 4 | The company has expanded its San Diego (US) campus dedicated to diagnostics and, in particular, blood typing. The expansion, at an approximate cost of $50 million (€43 million), has included the construction of a new plant that nearly doubles the surface area to 18,200 m2. Grifols has begun production of DG Gel cards, used in blood typing tests, and red blood cell reagents, used to detect antibodies….
Link Securities | The company, together with Forestalia, announced yesterday that they will double their partnership in Aragón (the combined cycle power plant in Escatrón with fifteen wind farms) to a total of 1,600 MW, which will enable a third party to develop a large data centre in the area, according to Expansión. With this scale, it would be the largest energy hybridisation project in Spain to date. Sources in…
Norbolsa | The company announces that it plans to seek a partner for the sale of 49% of the East Anglia Two offshore wind farm, valued at €5 billion. Thus, following the sale of 49% of East Anglia One and East Anglia Three, the company plans to seek a new partner for the second phase of this offshore development, which corresponds to a 960 MW development. Meanwhile, according to press…
Jefferies | With a low acceptance rate of 25%, BBVA’s takeover bid for Sabadell has reached a deadlock. We now expect management to focus on leaving the best possible impression. This implies the possibility of distributing 15% of market capitalisation in the short term and up to 40% in 2028. We expect the shares to react positively, given the implications that an acceptance level of less than 50% would have…
Bankinter | The payment corresponds to the FDA’s full approval on 2 October of the Zepzelca + Tecentriq (Roche) combination as a first-line maintenance treatment for adults with advanced small cell lung cancer whose disease has not progressed after first-line induction treatment with atezolizumab, carboplatin and etoposidei. Jazz Pharma is the exclusive licensee of Zepzelca for the US. Bankinter’s opinion: Positive news, despite which the stock fell yesterday, marking eight…